nach oben

Langenbeck's Archives of Surgery

Erschienen in:

18.08.2021 | State-of-the-Art Clinical Surgery

State-of-the-art surgery for hepatocellular carcinoma

verfasst von: Nikolaos Machairas, Diamantis I. Tsilimigras, Timothy M. Pawlik

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Hepatocellular carcinoma (HCC) is the most commonly diagnosed primary liver tumor with an increasing incidence worldwide. Management of patients with HCC is largely dictated by the presence of cirrhosis, disease stage, underlying liver function, and patient performance status.

Purpose

We provide an update on key aspects of surgical treatment options for patients with HCC.

Results & Conclusions

Liver resection and transplantation remain cornerstone treatment options for patients with early-stage disease and constitute the only potentially curative options for HCC. Selection of patients for surgical treatment should include a thorough evaluation of tumor characteristics and biology, as well as evidence-based use of various available treatment options to achieve optimal long-term outcomes for patients with HCC.

Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380:1450–1462. https://doi.org/10.1056/NEJMra1713263

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660CrossRef

McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13. https://doi.org/10.1002/hep.31288

Ganne-Carrie N, Nahon P (2019) Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol 70:284–293. https://doi.org/10.1016/j.jhep.2018.10.008

Younossi ZM, Henry L (2021) Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Rep 3:100305. https://doi.org/10.1016/j.jhepr.2021.100305

Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314. https://doi.org/10.1016/S0140-6736(18)30010-2

Tsilimigras DI, Bagante F, Moris D, Merath K, Paredes AZ, Sahara K et al (2019) Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: a multi-institutional analysis of 1,010 patients. Surgery 166:967–974. https://doi.org/10.1016/j.surg.2019.08.010

Tsilimigras DI, Bagante F, Sahara K, Moris D, Hyer JM, Wu L et al (2019) Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol 26:3693–3700. https://doi.org/10.1245/s10434-019-07580-9CrossRefPubMed

Vitale A, Farinati F, Finotti M, Di Renzo C, Brancaccio G, Piscaglia F, et al. (2021) Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications. Cancers (Basel) 13. https://doi.org/10.3390/cancers13071673

10.

Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA et al (2019) Guidelines insights: hepatobiliary cancers, version 2.2019. J Natl Compr Canc Netw 17:302–310. https://doi.org/10.6004/jnccn.2019.0019CrossRefPubMed

11.

Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928. https://doi.org/10.1002/1097-0142(19850815)56:4%3c918::aid-cncr2820560437%3e3.0.co;2-eCrossRefPubMed

12.

Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging score (JIS score). J Gastroenterol 38:207–215. https://doi.org/10.1007/s005350300038CrossRefPubMed

13.

Chok KS, Ng KK, Poon RT, Lo CM, Fan ST (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87. https://doi.org/10.1002/bjs.6358CrossRefPubMed

14.

Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T et al (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204:580–587. https://doi.org/10.1016/j.jamcollsurg.2007.01.035CrossRefPubMed

15.

Wei AC, Tung-Ping Poon R, Fan ST, Wong J (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90:33–41. https://doi.org/10.1002/bjs.4018CrossRefPubMed

16.

Rahnemai-Azar AA, Cloyd JM, Weber SM, Dillhoff M, Schmidt C, Winslow ER, et al. (2018) Update on liver failure following hepatic resection: strategies for prediction and avoidance of post-operative liver insufficiency. J Clin Transl Hepatol 6:97–104. https://doi.org/10.14218/JCTH.2017.00060

17.

Ribero D, Curley SA, Imamura H, Madoff DC, Nagorney DM, Ng KK et al (2008) Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol 15:986–992. https://doi.org/10.1245/s10434-007-9731-yCrossRefPubMed

18.

European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236. https://doi.org/10.1016/j.jhep.2018.03.019CrossRef

19.

Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L et al (2015) The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62:440–451. https://doi.org/10.1002/hep.27745CrossRefPubMed

20.

Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL et al (2001) Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 91:1479–1486. https://doi.org/10.1002/1097-0142(20010415)91:8%3c1479::aid-cncr1155%3e3.0.co;2-0CrossRefPubMed

21.

Yang B, Zheng B, Yang M, Zeng Z, Yang F, Pu J et al (2018) Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. Hepatol Int 12:417–428. https://doi.org/10.1007/s12072-018-9888-4CrossRefPubMed

22.

Wang H, Qian YW, Wu MC, Cong WM (2020) Liver resection is justified in patients with BCLC intermediate stage hepatocellular carcinoma without microvascular invasion. J Gastrointest Surg 24:2737–2747. https://doi.org/10.1007/s11605-019-04251-8CrossRefPubMed

23.

Chen S, Jin H, Dai Z, Wei M, Xiao H, Su T et al (2019) Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma. Cancer Med 8:1530–1539. https://doi.org/10.1002/cam4.2038CrossRefPubMedPubMedCentral

24.

Yin L, Li H, Li AJ, Lau WY, Pan ZY, Lai EC et al (2014) Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: a RCT. J Hepatol 61:82–88. https://doi.org/10.1016/j.jhep.2014.03.012CrossRefPubMed

25.

Hyun MH, Lee YS, Kim JH, Lee CU, Jung YK, Seo YS et al (2018) Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a meta-analysis of high-quality studies. Hepatology 68:977–993. https://doi.org/10.1002/hep.29883CrossRefPubMed

26.

Labgaa I, Demartines N, Melloul E (2019) Surgical resection versus transarterial chemoembolization for intermediate stage hepatocellular carcinoma (BCLC-B): an unsolved question. Hepatology 69:923. https://doi.org/10.1002/hep.30338CrossRefPubMed

27.

Santambrogio R, Kluger MD, Costa M, Belli A, Barabino M, Laurent A et al (2013) Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh’s A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB (Oxford) 15:78–84. https://doi.org/10.1111/j.1477-2574.2012.00594.xCrossRef

28.

Takemura N, Aoki T, Hasegawa K, Kaneko J, Arita J, Akamatsu N et al (2019) Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension. Br J Surg 106:1066–1074. https://doi.org/10.1002/bjs.11153CrossRefPubMed

29.

Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236:602–611. https://doi.org/10.1097/00000658-200211000-00010CrossRefPubMedPubMedCentral

30.

Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T (1987) Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 206:30–39. https://doi.org/10.1097/00000658-198707000-00005CrossRefPubMedPubMedCentral

31.

Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, et al. (2004) Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239:722–30; discussion 30–2. https://doi.org/10.1097/01.sla.0000124385.83887.d5

32.

Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N et al (2020) Liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation 104:1136–1142. https://doi.org/10.1097/TP.0000000000003174CrossRefPubMed

33.

Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L et al (2016) Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 65:1035–1041. https://doi.org/10.1136/gutjnl-2014-308513CrossRefPubMed

34.

Muscari F, Foppa B, Kamar N, Peron JM, Selves J, Suc B (2009) Liberal selection criteria for liver transplantation for hepatocellular carcinoma. Br J Surg 96:785–791. https://doi.org/10.1002/bjs.6619CrossRefPubMed

35.

Bento de Sousa JH, Calil IL, Tustumi F, da Cunha Khalil D, Felga GEG, de Arruda Pecora RA, et al. (2021) Comparison between Milan and UCSF criteria for liver transplantation in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Transl Gastroenterol Hepatol 6:11. https://doi.org/10.21037/tgh.2020.01.06

36.

Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, et al. (2012) Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology 143:986–94 e3; quiz e14–5. https://doi.org/10.1053/j.gastro.2012.05.052

37.

Zhu B, Wang J, Li H, Chen X, Zeng Y (2019) Living or deceased organ donors in liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford) 21:133–147. https://doi.org/10.1016/j.hpb.2018.11.004CrossRef

38.

Sugawara Y, Tamura S, Makuuchi M (2007) Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 25:310–312. https://doi.org/10.1159/000106910CrossRefPubMed

39.

Sotiropoulos GC, Spartalis E, Machairas N, Paul A, Malago M, Neuhauser M. (2018) Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison. Ann Gastroenterol 31:722–7. https://doi.org/10.20524/aog.2018.0301

40.

Nasralla D, Coussios CC, Mergental H, Akhtar MZ, Butler AJ, Ceresa CDL et al (2018) A randomized trial of normothermic preservation in liver transplantation. Nature 557:50–56. https://doi.org/10.1038/s41586-018-0047-9CrossRefPubMed

41.

Khorsandi SE, Yip VS, Cortes M, Jassem W, Quaglia A, O’Grady J et al (2016) Does donation after cardiac death utilization adversely affect hepatocellular cancer survival? Transplantation 100:1916–1924. https://doi.org/10.1097/TP.0000000000001150CrossRefPubMed

42.

Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D et al (2009) Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl 15:1028–1035. https://doi.org/10.1002/lt.21811CrossRefPubMed

43.

Ribero D, Abdalla EK, Thomas MB, Vauthey JN (2006) Liver resection in the treatment of hepatocellular carcinoma. Expert Rev Anticancer Ther 6:567–579. https://doi.org/10.1586/14737140.6.4.567CrossRefPubMed

44.

Menahem B, Lubrano J, Duvoux C, Mulliri A, Alves A, Costentin C et al (2017) Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: an attempt to perform an ideal meta-analysis. Liver Transpl 23:836–844. https://doi.org/10.1002/lt.24758CrossRefPubMed

45.

Adam R, Bhangui P, Vibert E, Azoulay D, Pelletier G, Duclos-Vallee JC et al (2012) Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg 256:883–891. https://doi.org/10.1097/SLA.0b013e318273bad0

46.

Breitenstein S, Apestegui C, Petrowsky H, Clavien PA (2009) “State of the art” in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg 33:797–803. https://doi.org/10.1007/s00268-008-9878-0CrossRefPubMed

47.

Chapelle T, Op De Beeck B, Huyghe I, Francque S, Driessen A, Roeyen G et al (2016) Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure? HPB (Oxford) 18:494–503. https://doi.org/10.1016/j.hpb.2015.08.002CrossRef

48.

Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ et al (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692. https://doi.org/10.2967/jnumed.106.038430CrossRefPubMed

49.

Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK, Belghiti J (2003) The small remnant liver after major liver resection: how common and how relevant? Liver Transpl 9:S18-25. https://doi.org/10.1053/jlts.2003.50194CrossRefPubMed

50.

Dixon M, Cruz J, Sarwani N, Gusani N (2021) The future liver remnant: definition, evaluation, and management. Am Surg 87:276–286. https://doi.org/10.1177/0003134820951451CrossRefPubMed

51.

Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM et al (2002) Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8:233–240. https://doi.org/10.1053/jlts.2002.31654CrossRefPubMed

52.

Hwang S, Ha TY, Song GW, Jung DH, Ahn CS, Moon DB et al (2015) Quantified risk assessment for major hepatectomy via the indocyanine green clearance rate and liver volumetry combined with standard liver volume. J Gastrointest Surg 19:1305–1314. https://doi.org/10.1007/s11605-015-2846-8CrossRefPubMed

53.

Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V et al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237:208–217. https://doi.org/10.1097/01.SLA.0000048447.16651.7BCrossRefPubMedPubMedCentral

54.

Terasawa M, Allard MA, Golse N, Sa Cunha A, Cherqui D, Adam R et al (2020) Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: an intent-to-treat analysis. Surgery 167:425–431. https://doi.org/10.1016/j.surg.2019.09.023CrossRefPubMed

55.

Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V (2006) Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93:1091–1098. https://doi.org/10.1002/bjs.5341CrossRefPubMed

56.

Tustumi F, Ernani L, Coelho FF, Bernardo WM, Junior SS, Kruger JAP et al (2018) Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford) 20:1109–1118. https://doi.org/10.1016/j.hpb.2018.06.1798CrossRef

57.

Guiu B, Quenet F, Escal L, Bibeau F, Piron L, Rouanet P et al (2017) Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol 27:3343–3352. https://doi.org/10.1007/s00330-017-4744-9CrossRefPubMed

58.

Hwang S, Ha TY, Ko GY, Kwon DI, Song GW, Jung DH et al (2015) Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg 39:2990–2998. https://doi.org/10.1007/s00268-015-3194-2CrossRefPubMed

59.

Panaro F, Giannone F, Riviere B, Sgarbura O, Cusumano C, Deshayes E, et al. (2019) Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr 8:329–37. https://doi.org/10.21037/hbsn.2019.07.06

60.

Guiu B, Herrero A, Panaro F. (2021) Liver venous deprivation: a bright future for liver metastases-but what about hepatocellular carcinoma? Hepatobiliary Surg Nutr 10:270–2. https://doi.org/10.21037/hbsn-21-7

61.

Raptis DA, Linecker M, Kambakamba P, Tschuor C, Muller PC, Hadjittofi C et al (2019) Defining benchmark outcomes for ALPPS. Ann Surg 270:835–841. https://doi.org/10.1097/SLA.0000000000003539CrossRefPubMed

62.

Chia DKA, Yeo Z, Loh SEK, Iyer SG, Madhavan K, Kow AWC (2018) ALPPS for hepatocellular carcinoma is associated with decreased liver remnant growth. J Gastrointest Surg 22:973–980. https://doi.org/10.1007/s11605-018-3697-xCrossRefPubMed

63.

Vennarecci G, Laurenzi A, Levi Sandri GB, Busi Rizzi E, Cristofaro M, Montalbano M et al (2014) The ALPPS procedure for hepatocellular carcinoma. Eur J Surg Oncol 40:982–988. https://doi.org/10.1016/j.ejso.2014.04.002CrossRefPubMed

64.

Petrowsky H, Linecker M, Raptis DA, Kuemmerli C, Fritsch R, Kirimker OE et al (2020) First long-term oncologic results of the ALPPS procedure in a large cohort of patients with colorectal liver metastases. Ann Surg 272:793–800. https://doi.org/10.1097/SLA.0000000000004330CrossRefPubMed

65.

Deng Z, Jin Z, Qin Y, Wei M, Wang J, Lu T et al (2021) Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study. World J Surg Oncol 19:95. https://doi.org/10.1186/s12957-021-02199-1CrossRefPubMedPubMedCentral

66.

Baili E, Tsilimigras DI, Filippou D, Ioannidis A, Bakopoulos A, Machairas N et al (2019) Associating liver partition and portal vein ligation for staged hepatectomy in patients with primary liver malignancies: a systematic review of the literature. J BUON 24:1371–1381PubMed

67.

Baili E, Tsilimigras DI, Moris D, Sahara K, Pawlik TM (2020) Technical modifications and outcomes after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for primary liver malignancies: a systematic review. Surg Oncol 33:70–80. https://doi.org/10.1016/j.suronc.2020.01.010CrossRefPubMed

68.

Tsilimigras DI, Mehta R, Guglielmi A, Ratti F, Marques HP, Soubrane O et al (2020) Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: a novel tumor-burden based prediction model. J Surg Oncol 122:955–963. https://doi.org/10.1002/jso.26091CrossRefPubMed

69.

Wei T, Zhang XF, Xue F, Bagante F, Ratti F, Marques HP et al (2021) Multi-institutional development and external validation of a nomogram for prediction of extrahepatic recurrence after curative-intent resection for hepatocellular carcinoma. Ann Surg Oncol. https://doi.org/10.1245/s10434-021-10142-7CrossRefPubMed

70.

Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243:229–235. https://doi.org/10.1097/01.sla.0000197706.21803.a1CrossRefPubMedPubMedCentral

71.

Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J et al (2010) Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 8:55. https://doi.org/10.1186/1477-7819-8-55CrossRefPubMedPubMedCentral

72.

Machairas N, Papaconstantinou D, Stamopoulos P, Prodromidou A, Garoufalia Z, Spartalis E, et al. (2018) The emerging role of laparoscopic liver resection in the treatment of recurrent hepatocellular carcinoma: a systematic review. Anticancer Res 38:3181–6. https://doi.org/10.21873/anticanres.12582

73.

Miyama A, Morise Z, Aldrighetti L, Belli G, Ratti F, Cheung TT, et al. (2021) Multicenter propensity score-based study of laparoscopic repeat liver resection for hepatocellular carcinoma: a subgroup analysis of cases with tumors far from major vessels. Cancers (Basel) 13.https://doi.org/10.3390/cancers13133187

74.

Morise Z, Aldrighetti L, Belli G, Ratti F, Belli A, Cherqui D et al (2020) Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study. Br J Surg 107:889–895. https://doi.org/10.1002/bjs.11436CrossRefPubMed

75.

Peng Y, Liu F, Wei Y, Li B (2019) Outcomes of laparoscopic repeat liver resection for recurrent liver cancer: a system review and meta-analysis. Medicine (Baltimore) 98:e17533. https://doi.org/10.1097/MD.0000000000017533

76.

Bhangui P, Allard MA, Vibert E, Cherqui D, Pelletier G, Cunha AS et al (2016) Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes? Ann Surg 264:155–163. https://doi.org/10.1097/SLA.0000000000001442CrossRefPubMed

77.

Poon RT, Fan ST, Lo CM, Liu CL, Wong J (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373–382. https://doi.org/10.1097/00000658-200203000-00009CrossRefPubMedPubMedCentral

78.

Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, et al. (2003) Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 238:315–21; discussion 21–3. https://doi.org/10.1097/01.sla.0000086548.84705.ef

79.

Moris D, Tsilimigras DI, Kostakis ID, Ntanasis-Stathopoulos I, Shah KN, Felekouras E et al (2018) Anatomic versus non-anatomic resection for hepatocellular carcinoma: a systematic review and meta-analysis. Eur J Surg Oncol 44:927–938. https://doi.org/10.1016/j.ejso.2018.04.018CrossRefPubMed

80.

Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350PubMed

81.

Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131:311–317. https://doi.org/10.1067/msy.2002.121892CrossRefPubMed

82.

Kawaguchi Y, Nomura Y, Nagai M, Koike D, Sakuraoka Y, Ishida T et al (2017) Liver transection using indocyanine green fluorescence imaging and hepatic vein clamping. Br J Surg 104:898–906. https://doi.org/10.1002/bjs.10499CrossRefPubMed

83.

Nakaseko Y, Ishizawa T, Saiura A (2018) Fluorescence-guided surgery for liver tumors. J Surg Oncol 118:324–331. https://doi.org/10.1002/jso.25128CrossRefPubMed

84.

Kawaguchi Y, Lillemoe HA, Vauthey JN (2020) Surgical resection: old dog, any new tricks? Clin Liver Dis 24:637–655. https://doi.org/10.1016/j.cld.2020.07.004CrossRefPubMed

85.

Poon RT, Fan ST, Ng IO, Wong J (2000) Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg 231:544–551. https://doi.org/10.1097/00000658-200004000-00014CrossRefPubMedPubMedCentral

86.

Jeng KS, Jeng WJ, Sheen IS, Lin CC, Lin CK (2013) Is less than 5 mm as the narrowest surgical margin width in central resections of hepatocellular carcinoma justified? Am J Surg 206:64–71. https://doi.org/10.1016/j.amjsurg.2012.06.010CrossRefPubMed

87.

Lee W, Han HS, Ahn S, Yoon YS, Cho JY, Choi Y (2018) Correlation between resection margin and disease recurrence with a restricted cubic spline model in patients with resected hepatocellular carcinoma. Dig Surg 35:520–531. https://doi.org/10.1159/000485805CrossRefPubMed

88.

Nitta H, Allard MA, Sebagh M, Golse N, Ciacio O, Pittau G et al (2021) Ideal surgical margin to prevent early recurrence after hepatic resection for hepatocellular carcinoma. World J Surg 45:1159–1167. https://doi.org/10.1007/s00268-020-05881-9CrossRefPubMed

89.

Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S (2005) Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 103:299–306. https://doi.org/10.1002/cncr.20798CrossRefPubMed

90.

Vigano L, Procopio F, Cimino MM, Donadon M, Gatti A, Costa G et al (2016) Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort. Ann Surg Oncol 23:1352–1360. https://doi.org/10.1245/s10434-015-5009-yCrossRefPubMed

91.

Donadon M, Terrone A, Procopio F, Cimino M, Palmisano A, Vigano L et al (2019) Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients. Surgery 165:897–904. https://doi.org/10.1016/j.surg.2018.12.002CrossRefPubMed

92.

Wu L, Tsilimigras DI, Merath K, Hyer JM, Paredes AZ, Mehta R et al (2020) Minimally invasive liver resection for early-stage hepatocellular carcinoma: inconsistent outcomes from matched or weighted cohorts. J Gastrointest Surg 24:560–568. https://doi.org/10.1007/s11605-019-04221-0CrossRefPubMed

93.

Machairas N, Sotiropoulos GC. (2019) Laparoscopic liver surgery: yesterday, today and tomorrow. Hepatobiliary Surg Nutr 8:324–6. https://doi.org/10.21037/hbsn.2019.01.12

94.

Sotiropoulos GC, Prodromidou A, Kostakis ID, Machairas N (2017) Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma. Updates Surg 69:291–311. https://doi.org/10.1007/s13304-017-0421-4CrossRefPubMed

95.

Tsilimigras DI, Moris D, Vagios S, Merath K, Pawlik TM (2018) Safety and oncologic outcomes of robotic liver resections: a systematic review. J Surg Oncol 117:1517–1530. https://doi.org/10.1002/jso.25018CrossRefPubMed

96.

Cai W, Liu Z, Xiao Y, Zhang W, Tang D, Cheng B et al (2019) Comparison of clinical outcomes of laparoscopic versus open surgery for recurrent hepatocellular carcinoma: a meta-analysis. Surg Endosc 33:3550–3557. https://doi.org/10.1007/s00464-019-06996-4CrossRefPubMed

97.

Wang ZY, Chen QL, Sun LL, He SP, Luo XF, Huang LS et al (2019) Laparoscopic versus open major liver resection for hepatocellular carcinoma: systematic review and meta-analysis of comparative cohort studies. BMC Cancer 19:1047. https://doi.org/10.1186/s12885-019-6240-xCrossRefPubMedPubMedCentral

98.

Machairas N, Papaconstantinou D, Tsilimigras DI, Moris D, Prodromidou A, Paspala A et al (2019) Comparison between robotic and open liver resection: a systematic review and meta-analysis of short-term outcomes. Updates Surg 71:39–48. https://doi.org/10.1007/s13304-019-00629-0CrossRefPubMed

99.

Machairas N, Kostakis ID, Schizas D, Kykalos S, Nikiteas N, Sotiropoulos GC (2021) Meta-analysis of laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma. Updates Surg 73:59–68. https://doi.org/10.1007/s13304-020-00930-3CrossRefPubMed

100.

Xing L, Guo HB, Kan JL, Liu SG, Lv HT, Liu JH et al (2020) Clinical outcome of open surgery versus laparoscopic surgery for cirrhotic hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol 32:239–245. https://doi.org/10.1097/MEG.0000000000001495CrossRefPubMed

101.

Kanazawa A, Tsukamoto T, Shimizu S, Kodai S, Yamazoe S, Yamamoto S et al (2013) Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis. Surg Endosc 27:2592–2597. https://doi.org/10.1007/s00464-013-2795-9CrossRefPubMed

102.

Sotiropoulos GC, Prodromidou A, Machairas N (2017) Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma: the European experience. J BUON 22:1160–1171PubMed

103.

Dagher I, Gayet B, Tzanis D, Tranchart H, Fuks D, Soubrane O et al (2014) International experience for laparoscopic major liver resection. J Hepatobiliary Pancreat Sci 21:732–736. https://doi.org/10.1002/jhbp.140CrossRefPubMed

104.

Halls MC, Cipriani F, Berardi G, Barkhatov L, Lainas P, Alzoubi M et al (2018) Conversion for unfavorable intraoperative events results in significantly worse outcomes during laparoscopic liver resection: lessons learned from a multicenter review of 2861 cases. Ann Surg 268:1051–1057. https://doi.org/10.1097/SLA.0000000000002332CrossRefPubMed

105.

Buscarini E, Savoia A, Brambilla G, Menozzi F, Reduzzi L, Strobel D et al (2005) Radiofrequency thermal ablation of liver tumors. Eur Radiol 15:884–894. https://doi.org/10.1007/s00330-005-2652-xCrossRefPubMed

106.

Cheung TT, Ma KW, She WH. (2021) A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. Hepatobiliary Surg Nutr 10:193–209. https://doi.org/10.21037/hbsn.2020.03.11

107.

Shin SW, Ahn KS, Kim SW, Kim TS, Kim YH, Kang KJ (2021) Liver resection versus local ablation therapies for hepatocellular carcinoma within the milan criteria: a systematic review and meta-analysis. Ann Surg 273:656–666. https://doi.org/10.1097/SLA.0000000000004350CrossRefPubMed

108.

Simon CJ, Dupuy DE, Mayo-Smith WW (2005) Microwave ablation: principles and applications. Radiographics 25(Suppl 1):S69-83. https://doi.org/10.1148/rg.25si055501CrossRefPubMed

109.

Liu W, Zou R, Wang C, Qiu J, Shen J, Liao Y et al (2019) Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis. Ther Adv Med Oncol 11:1758835919874652. https://doi.org/10.1177/1758835919874652CrossRefPubMed

110.

Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H (2019) Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma </=5 cm: a propensity score-matched analysis. Surgery 166:254–262. https://doi.org/10.1016/j.surg.2019.05.007CrossRefPubMed

111.

Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A et al (2018) The tumor burden score: a new “metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg 267:132–141. https://doi.org/10.1097/SLA.0000000000002064CrossRefPubMed

112.

Tsilimigras DI, Pawlik TM (2020) Tumour burden score: an authentic, easy-to-use prognostic marker for hepatocellular carcinoma. Br J Surg 107:e626. https://doi.org/10.1002/bjs.11926CrossRefPubMed

113.

Tsilimigras DI, Mehta R, Paredes AZ, Moris D, Sahara K, Bagante F et al (2020) Overall tumor burden dictates outcomes for patients undergoing resection of multinodular hepatocellular carcinoma beyond the Milan criteria. Ann Surg 272:574–581. https://doi.org/10.1097/SLA.0000000000004346CrossRefPubMed

114.

Tsilimigras DI, Moris D, Hyer JM, Bagante F, Sahara K, Moro A et al (2020) Hepatocellular carcinoma tumour burden score to stratify prognosis after resection. Br J Surg 107:854–864. https://doi.org/10.1002/bjs.11464CrossRefPubMed

Titel: State-of-the-art surgery for hepatocellular carcinoma
verfasst von: Nikolaos Machairas
Diamantis I. Tsilimigras
Timothy M. Pawlik
Publikationsdatum: 18.08.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 7/2021
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-021-02298-3

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

State-of-the-art surgery for hepatocellular carcinoma

Abstract

Background

Purpose

Results & Conclusions

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

Recycling im OP – möglich, aber teuer

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

Nur selten Nachblutungen nach Abszesstonsillektomie

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Background

Purpose

Results & Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2021

The technical aspects of ex vivo hepatectomy with autotransplantation: a systematic review and meta-analysis

Minimally invasive ileal pouch-anal anastomosis for patients with obesity: a propensity score-matched analysis

Severe mesenteric traction syndrome is associated with increased systemic inflammatory response, endothelial dysfunction, and major postoperative morbidity

Laparoscopic biopsy and staging for locally advanced pancreatic cancer: experiences of 76 consecutive patients in a single institution

High postoperative neutrophil–lymphocyte ratio and low preoperative lymphocyte-monocyte ratio predict poor prognosis in gastric cancer patients receiving gastrectomy with positive lavage cytology: a retrospective cohort study

Preoperative lymphocyte-to-monocyte ratio is the most predictive inflammatory response marker of survival in gastric cancer

Update Chirurgie